OQROGet OQRO Pro
Politician trade (House)

Eli Lilly (LLY)Rep. Jonathan Jackson (IL01) disclosed a sale $15K–$50K

Rep. Jonathan Jackson (IL01) disclosed a sale of Eli Lilly in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
41 days
Disclosure lag
Traded
Jun 3, 2025
Disclosed
Jul 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Dec 11, 2024Congress · 2 peopleMembers of Congress: 2 purchases
  3. Mar 3, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  4. Mar 10, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  5. Apr 7, 2025FDAFDA drug approval: Cyramza
  6. Apr 7, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  7. Apr 8, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  8. Apr 9, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  9. Apr 11, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  10. Apr 15, 2025CongressDisclosed sale of LLY — reported range $15,001 - $50,000
  11. Apr 21, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
  12. Apr 23, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  13. May 1, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  14. May 5, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  15. May 6, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  16. May 12, 2025CongressDisclosed sale of LLY — reported range $100,001 - $250,000
  17. May 13, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  18. May 14, 2025InsiderOfficer sold ~$937K of LLY shares in the open market
  19. May 14, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  20. May 21, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  21. May 27, 2025InsiderOfficer sold ~$716K of LLY shares in the open market
  22. May 30, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  23. Jun 3, 2025 · this disclosureCongressDisclosed sale of LLY — reported range $15,001 - $50,000

What came next

  1. Jun 9, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  2. Jul 1, 2025FDAFDA drug approval: Kisunla
  3. Jul 10, 2025Congress · 1 personMembers of Congress: 2 purchases
  4. Jul 16, 2025Congress · 1 personMembers of Congress: 2 sales
  5. Jul 24, 2025Insider · 1 personInsiders: 6 sales (~$225.4M)
  6. Aug 8, 2025InsiderDirector purchased ~$128K of LLY shares in the open market
  7. Aug 11, 2025InsiderOfficer sold ~$784K of LLY shares in the open market
  8. Aug 11, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  9. Aug 12, 2025Insider · 4 peopleInsiders: 5 purchases (~$2.8M)
  10. Aug 13, 2025Insider · 2 peopleInsiders: 2 purchases (~$1.1M)
  11. Aug 14, 2025Congress · 2 peopleMembers of Congress: 2 purchases, 1 sale
  12. Aug 15, 2025InsiderCFO purchased ~$495K of LLY shares in the open market
  13. Aug 22, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  14. Aug 28, 2025InsiderOfficer sold ~$735K of LLY shares in the open market
  15. Sep 18, 2025Insider · 1 personInsiders: 5 sales (~$81.5M)
  16. Sep 19, 2025Insider · 1 personInsiders: 2 sales (~$18.1M)
  17. Sep 25, 2025FDAFDA drug approval: Inluriyo
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Rep. Jonathan Jackson (IL01)

The full history of Rep. Jonathan Jackson (IL01) is on the profile page.

How this filing works

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data